BeiGene Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BGNE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Apr 24	SellUS$7,475,024	John Oyler	Individual	50,000	US$154.21
29 Feb 24	SellUS$66,331	Julia Wang	Individual	397	US$167.08
26 Jan 24	BuyUS$23,699,905	Capital Research and Management Company	Company	146,849.93	US$161.39
14 Nov 23	SellUS$198,550,000	Baker Bros. Advisors LP	Company	1,100,000	US$180.50
02 Aug 23	BuyUS$544,881	Capital Research and Management Company	Company	33,854.3	US$16.09
31 Jul 23	SellUS$171,059	Chan Lee	Individual	791	US$216.26
03 Jul 23	SellUS$84,747	Julia Wang	Individual	472	US$179.55
26 Jun 23	SellUS$272,636	Xiaobin Wu	Individual	1,495	US$182.37
26 Jun 23	SellUS$201,567	Wang Lai	Individual	1,108	US$183.15
23 Jun 23	SellUS$153,594	Julia Wang	Individual	840	US$182.85
20 Jun 23	SellUS$254,955	Wang Lai	Individual	1,325	US$192.42
20 Jun 23	SellUS$36,583	Julia Wang	Individual	190	US$192.54
20 Jun 23	SellUS$337,356	Xiaobin Wu	Individual	1,753	US$192.44
14 Jun 23	SellUS$14,311,945	Hillhouse Investment Management, Ltd.	Company	68,056	US$211.45
12 Jun 23	SellUS$40,962,415	Hillhouse Investment Management, Ltd.	Company	189,353	US$218.14
07 Jun 23	SellUS$739,599	Xiaobin Wu	Individual	3,291	US$226.15
07 Jun 23	SellUS$103,828	Wang Lai	Individual	462	US$226.15

Insider Buying: BGNE insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 79.94% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.1%	Amgen Inc.	18,938,119	US$2.8b	0%	no data
10.1%	Baker Bros. Advisors LP	10,576,080	US$1.6b	0%	18.58%
9.52%	HHLR Advisors, Ltd.	9,955,172	US$1.5b	0%	25.32%
8.05%	Capital Research and Management Company	8,414,438	US$1.3b	10.7%	0.07%
4.95%	Hillhouse Investment Management, Ltd.	5,177,085	US$770.6m	-52.9%	6.33%
4.78%	PRIMECAP Management Company	5,001,839	US$744.5m	0.26%	0.56%
3.77%	Baillie Gifford & Co.	3,946,611	US$587.5m	-3.61%	0.27%
3.44%	John Oyler	3,601,461	US$536.1m	-11.2%	no data
2.88%	Temasek Holdings (Private) Limited	3,014,171	US$448.7m	0%	0.45%
2.69%	BlackRock, Inc.	2,815,950	US$419.2m	-1.69%	no data
1.94%	T. Rowe Price Group, Inc.	2,026,332	US$301.6m	6.18%	0.03%
1.88%	The Vanguard Group, Inc.	1,969,614	US$293.2m	0.23%	no data
1.57%	FMR LLC	1,640,879	US$244.2m	-3.96%	0.02%
1.2%	Bosera Asset Management Co., Ltd.	1,252,593	US$186.4m	0%	1.0%
0.81%	GF Fund Management Co., Ltd.	848,118	US$126.2m	0%	0.31%
0.77%	Xiaodong Wang	805,732	US$119.9m	0%	no data
0.51%	ICBC Credit Suisse Asset Management Co., Ltd.	533,770	US$79.5m	0%	0.59%
0.48%	Tavistock Life Sciences	500,000	US$74.4m	0%	4.27%
0.41%	China Asset Management Co. Ltd.	426,500	US$63.5m	-1.24%	0.1%
0.39%	Artal Group S.A.	404,782	US$60.3m	0.07%	1.41%
0.35%	Guangzhou Development District Holding Group Limited	368,385	US$54.8m	0%	no data
0.35%	SDIC Unity Capital Co., Ltd.	368,385	US$54.8m	0%	5.4%
0.34%	Public Investment Fund	354,385	US$52.8m	0%	0.03%
0.31%	Vestal Point Capital, LP	325,000	US$48.4m	0%	4.58%
0.29%	Wanjia Asset Management Co., Ltd.	307,600	US$45.8m	0%	0.84%